Publicacions en col·laboració amb investigadors/es de Emory University School of Medicine (2)

2020

  1. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

    The Lancet Oncology, Vol. 21, Núm. 2, pp. 271-282

2019

  1. Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the committee for medicinal products for human use (chmp)

    Annals of Oncology